HMGB2 in endocrine resistant breast cancer. HMGB2 in endocrine resistant breast cancer
收藏NIAID Data Ecosystem2026-03-09 收录
官方服务：
资源简介：
HMGB2 and ER ChIPseq was investigated in the MCF-7 endocrine sensitive and LY2 endocrine resistant cell lines upon treatment with Tamoxifen.
创建时间：
2014-10-22
